Cargando…

Vaccination with an inactivated canine influenza H3N2 virus vaccine is safe and elicits an immune response in cats

OBJECTIVES: The aim of this study was to evaluate safety and seroconversion when an inactivated H3N2 canine influenza virus (CIV) vaccine was administered to cats. METHODS: Twenty 7–8-week-old seronegative cats were randomly assigned to two groups of 10 animals each. Cats in treatment group T01 were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velineni, Sridhar, Hainer, Nicole, Conlee, Douglas, Hutchinson, Kendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990454/ https://www.ncbi.nlm.nih.gov/pubmed/31986978 http://dx.doi.org/10.1177/1098612X19833261

Ejemplares similares

Experimental veterinary SARS-CoV-2 vaccine cross neutralization of the Delta (B.1.617.2) variant virus in cats
por: Hoyte, Ashley, et al.
Publicado: (2022)

Human immune responses elicited by an intranasal inactivated H5 influenza vaccine
por: Ainai, Akira, et al.
Publicado: (2020)

Diagnostic performances of two rapid tests for detection of feline leukemia virus antigen in sera of experimentally feline leukemia virus-infected cats
por: Krecic, Matthew R, et al.
Publicado: (2018)

Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine
por: Fan, Shengtao, et al.
Publicado: (2021)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

Molecular identification of the vaccine strain from the inactivated oil emulsion H9N2 low pathogenic avian influenza vaccine
por: Choi, Jun-Gu, et al.
Publicado: (2010)

Protective efficacy of an inactivated vaccine against H9N2 avian influenza virus in ducks
por: Teng, Qiaoyang, et al.
Publicado: (2015)

Inactivated canine coronavirus vaccine
Publicado: (1986)

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study
por: Hu, Yuemei, et al.
Publicado: (2019)

Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses
por: Allen, James D., et al.
Publicado: (2018)

Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals
por: Li, Juan, et al.
Publicado: (2021)

Correction: Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses
por: Allen, James D., et al.
Publicado: (2018)

Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months
por: Mordant, Francesca L., et al.
Publicado: (2022)

Serological survey of canine H3N2, pandemic H1N1/09, and human seasonal H3N2 influenza viruses in cats in northern China, 2010–2014
por: Zhang, Xuxiao, et al.
Publicado: (2015)

Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India
por: Agarkhedkar, Sharad, et al.
Publicado: (2019)

Differential Gene Expression Elicited by Children in Response to the 2015–2016 Live Attenuated vs. Inactivated Influenza Vaccine
por: Zimmerman, Richard, et al.
Publicado: (2017)

2743. Safety of Recombinant Influenza Vaccine Compared with Inactivated Influenza Vaccine in Adults
por: Hansen, John, et al.
Publicado: (2019)

Impact of various vaccine boosters on neutralization against omicron following prime vaccinations with inactivated or adenovirus-vectored vaccine
por: Huang, Qingrui, et al.
Publicado: (2022)

Immunogenicity of an Inactivated Canine Adenovirus Type 1 Vaccine for Foxes
por: Fu, Yang, et al.
Publicado: (2022)

Inactivated Whole Virus Influenza A (H5N1) Vaccine
por: Vajo, Zoltan, et al.
Publicado: (2007)

Characterization of a whole, inactivated influenza (H5N1) vaccine
por: Tada, Yoshikazu
Publicado: (2008)

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

Healthy elderly and influenza vaccination
por: Heins, Marianne J., et al.
Publicado: (2018)

1059 Expanded immunogenicity of high-dose inactivated influenza vaccine compared to standard-dose inactivated influenza vaccine in older adults
por: Diazgranados, Carlos, et al.
Publicado: (2014)

Membrane-bound IL-12 and IL-23 serve as potent mucosal adjuvants when co-presented on whole inactivated influenza vaccines
por: Khan, Tila, et al.
Publicado: (2014)

Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease
por: Yule, Terecita D., et al.
Publicado: (1997)

Safety, Immunogenicity and Duration of Immunity Elicited by an Inactivated Bovine Ephemeral Fever Vaccine
por: Aziz-Boaron, Orly, et al.
Publicado: (2013)

Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity
por: Kim, Eun-Do, et al.
Publicado: (2015)

In-Vitro Inactivation of Sabin-Polioviruses for Development of Safe and Effective Polio Vaccine
por: Abd-Elghaffar, Asmaa A., et al.
Publicado: (2020)

Immunogenicity assay of the Leishmune(®) vaccine against canine visceral leishmaniasis in Brazil
por: Borja-Cabrera, G.P., et al.
Publicado: (2008)

Evidence of canine parvovirus transmission to a civet cat (Paradoxurus musangus) in Singapore
por: Mendenhall, Ian H., et al.
Publicado: (2016)

Previous SARS‐CoV‐2 infection or a third dose of vaccine elicited cross‐variant neutralising antibodies in vaccinated solid‐organ transplant recipients
por: Chang, Chih‐Chao, et al.
Publicado: (2022)

The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys
por: Muraki, Yuko, et al.
Publicado: (2015)

Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
por: Wu, Songjie, et al.
Publicado: (2021)

Standardisation of inactivated influenza vaccines—Learning from history
por: Wood, John M., et al.
Publicado: (2018)

An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection
por: Ni, Yawei, et al.
Publicado: (2018)

Update of inactivated equine influenza vaccine strain in Japan
por: GAMOH, Koichiro, et al.
Publicado: (2017)

Simultaneous Influenza Vaccination and Hymenoptera Venom Immunotherapy Is Safe
por: Czerwińska, Ewa, et al.
Publicado: (2021)

Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
por: Kon, Theone C., et al.
Publicado: (2016)

Neutralizing Antibody Response in Dogs and Cats Inoculated with Commercial Inactivated Rabies Vaccines
por: SHIRAISHI, Rikiya, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_99d00asdt9a1gdashdhgcaf3bf